Therapy Unblinded: Inside MDMA Research Part 2 - podcast episode cover

Therapy Unblinded: Inside MDMA Research Part 2

Jul 26, 20241 hr 4 minSeason 1Ep. 33
--:--
--:--
Download Metacast podcast app
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episode description

Dr. Chantelle Thomas and Dr. Ingmar Gorman discuss the safety and ethical considerations of MDMA-assisted psychotherapy for PTSD, including standardization, non-directive approach, and adherence to therapy protocol. They also explore complex power dynamics in therapeutic relationships, ethical nuances of supporting participants in psychedelic studies, and the importance of representing a diverse population in psychedelic trials. 

(00:00:00) Introduction

(00:10:30) Therapist-participant relationships in psychedelic-assisted therapy trial.

(00:14:58) Challenges in supporting participants in psychedelic studies after the end of the trial.

(00:23:11) Standardizing therapy for MDMA-assisted therapy trial.

(00:32:11) The importance of non-directional support.

(00:36:37) Operationalizing therapy techniques to ensure consistency and address power imbalances.

(00:43:06) Psychedelic therapy adherence and rating systems.

(00:50:08) Therapist flexibility in the trial.

(00:59:41) Inclusion of diverse participants.

Dr. Chantelle Thomas, Executive Clinical Director Windrose Recovery: https://windroserecovery.com/

Integrata:  www.integratahealing.com

Dr. Ingmar Gorman: https://www.ingmargorman.com/about

Lykos: https://lykospbc.com

 

 

 

 

 

For the best experience, listen in Metacast app for iOS or Android